We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Investigation of Abiomed Marketing Practices Shadows Strong Quarter
Investigation of Abiomed Marketing Practices Shadows Strong Quarter
November 9, 2012
Cardiac devicemaker Abiomed is under scrutiny for its marketing and labeling of the Impella 2.5 heart pump, the company said in a Nov. 1 earnings statement covering the second quarter of fiscal 2013.